Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Kendra Demaris"'
Autor:
Danial E. Baker, Kendra Demaris
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::043e6a2b3dceaef78af460e3660d0745
https://europepmc.org/articles/PMC5135434/
https://europepmc.org/articles/PMC5135434/
Publikováno v:
Hospital Pharmacy. 48:231-240
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also r
Publikováno v:
Hospital Pharmacy. 47:788-793
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also r
Publikováno v:
Hospital Pharmacy. 47:721-724
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also r
Publikováno v:
Hospital Pharmacy. 47:544-549
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also r
Publikováno v:
Hospital Pharmacy. 47:463-470
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also r
Publikováno v:
Hospital Pharmacy. 47:375-381
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also r
Publikováno v:
Hospital pharmacy. 48(9)
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also r
Publikováno v:
American Journal of Pharmaceutical Education. 80:5
To determine how medical literature evaluation (MLE) is being taught across the United States and to summarize methods for teaching and assessing MLE.An 18-question survey was administered to faculty members whose primary responsibility was teaching
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
The 2014 American Diabetes Association guidelines denote four means of diagnosing diabetes. The first of these is a glycosylated hemoglobin (HbA1c) >6.5%. This literature review summarizes studies (n=47) in the USA examining the significance, strengt